Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ciprés Grupo Médico
Mexico
- Ownership
- Private
- Development stage
- Other
01
Overview
Ciprés Grupo Médico has published peer-reviewed research involving mutation screening for the FOXE1 gene in patients with complex syndromes including cleft lip, hypothyroidism, and thyroid carcinoma. The group appears to specialize in genomic DNA isolation and molecular diagnostics for rare or complex diseases.
- Therapeutic areas
- OtherOncologyEndocrinologyRare Diseases
- Modalities
- Genetic testingGenomic analysis
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on Ciprés Grupo Médico.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ciprés Grupo Médico.